在晚期帕金森病中,通过注入气的超热蒸汽给药的Mucuna豆
Ryuji Neshige1, Shuichiro Neshige1
1Medical Corporation, Neshige Neurology Clinic, Kurume, Japan.
Clinical parkinsonism & related disorders
|April 22, 2024
概括
豆 (MB) 为帕金森病的症状管理提供了一个自然的替代方案. 每天口服1-3g的剂量是有效的,随着阴道注射成为增强疗效的潜在选择.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 民族植物学 民族植物学
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病.
- 利沃多巴 (L-dopa) 是一种主要治疗方法,但疗效可能会下降.
- 正在探索PD管理的自然主义方法.
研究的目的:
- 对帕金森病患者使用Mucuna豆 (MB) 的使用进行审查.
- 为了分析MB的剂量和施用方法.
- 评估MB作为替代或辅助疗法的可行性.
主要方法:
- 200名帕金森病患者的回顾性审查.
- 分析Mucuna豆提取物 (MBE) 口服的情况.
- 考虑使用替代的注射途径,比如打阴道.
主要成果:
- 患者每天接受1-3g的MBE,溶于热水中.
- 口服MBE显示了治疗效果.
- 在没有足够的口服L-dopa疗效的情况下,考虑对MBE进行阴囊注射.
结论:
- 豆 (MB) 代表了对帕金森病的L-多巴的潜在天然来源.
- 标准化的口服剂量 (1-3g/天) 似乎是可行的.
- 研究替代的输送方法,如阴道水,可能会改善特定患者亚组的治疗结果.
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541